Literature DB >> 16260201

Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids (EMMY trial): peri- and postprocedural results from a randomized controlled trial.

Wouter J K Hehenkamp1, Nicole A Volkers, Peter F J Donderwinkel, Sjoerd de Blok, Erwin Birnie, Willem M Ankum, Jim A Reekers.   

Abstract

OBJECTIVE: This was a randomized controlled trial to evaluate the safety of uterine artery embolization (UAE) compared with hysterectomy. STUDY
DESIGN: Twenty-eight Dutch hospitals recruited 177 patients with symptomatic uterine fibroids and menorrhagia who were eligible for hysterectomy. Patients were randomized to UAE (n = 88) or hysterectomy (n = 89). In this paper we evaluate the peri- and postprocedural complications, length of hospital stay, unscheduled visits, and readmission rates up to 6 weeks' post-intervention. Analysis was by intention to treat.
RESULTS: Bilateral UAE failure occurred in 4 patients (4.9%). Major complications occurred in 4.9% (UAE) and 2.7% (hysterectomy) of cases (P = .68). The minor complication rate from discharge until 6 weeks after was significantly higher in the UAE group than in the hysterectomy group (58.0% vs 40.0%; RR 1.45 [1.04-2.02]; P = .024). UAE patients were more often readmitted (11.1% vs 0%; P = .003). Total length of hospital stay was significantly shorter in UAE patients (mean [SD]: 2.5 [2.7] vs 5.1 [1.3], P < .001).
CONCLUSION: UAE is a procedure similar to hysterectomy with a low major complication rate and with a reduced length of hospital stay. Higher readmission rates after UAE stress the need for careful postprocedural follow-up.

Entities:  

Mesh:

Year:  2005        PMID: 16260201     DOI: 10.1016/j.ajog.2005.05.017

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  30 in total

1.  Uterine artery embolisation versus hysterectomy for leiomyomas: primary and 2-year follow-up results of a randomised prospective clinical trial.

Authors:  Anu Ruuskanen; Maritta Hippeläinen; Petri Sipola; Hannu Manninen
Journal:  Eur Radiol       Date:  2010-06-06       Impact factor: 5.315

Review 2.  Uterine artery embolisation to treat symptomatic uterine fibroids.

Authors:  A Watkinson; A Nicholson
Journal:  BMJ       Date:  2007-10-06

3.  Uterine Artery Embolization in the Management of Symptomatic Uterine Fibroids: An Overview of Complications and Follow-up.

Authors:  Tami C Carrillo
Journal:  Semin Intervent Radiol       Date:  2008-12       Impact factor: 1.513

Review 4.  Fibroid Expulsion after Uterine Artery Embolization.

Authors:  Emily Ochmanek; Matthew A Brown; Paul J Rochon
Journal:  Semin Intervent Radiol       Date:  2019-05-22       Impact factor: 1.513

Review 5.  Fibroids (uterine myomatosis, leiomyomas).

Authors:  Anne Lethaby; Beverley Vollenhoven
Journal:  BMJ Clin Evid       Date:  2015-06-02

6.  Four-dimensional transcatheter intra-arterial perfusion MR imaging before and after uterine artery embolization in the rabbit VX2 tumor model.

Authors:  Johnathan C Chung; Dingxin Wang; Robert J Lewandowski; Richard Tang; Howard B Chrisman; Robert L Vogelzang; Gayle E Woloschak; Andrew C Larson; Reed A Omary; Robert K Ryu
Journal:  J Magn Reson Imaging       Date:  2010-05       Impact factor: 4.813

Review 7.  Current evidence on uterine embolization for fibroids.

Authors:  James B Spies
Journal:  Semin Intervent Radiol       Date:  2013-12       Impact factor: 1.513

Review 8.  Pregnancy success and outcomes after uterine fibroid embolization: updated review of published literature.

Authors:  Parker E Ludwig; Trevor J Huff; Meaghan M Shanahan; Joseph M Stavas
Journal:  Br J Radiol       Date:  2019-10-08       Impact factor: 3.039

9.  The transcervical expulsion of a large fibroid.

Authors:  Daniel Stott; Muhannad Zakaria
Journal:  BMJ Case Rep       Date:  2012-09-24

10.  MRI-guided focused ultrasound surgery for uterine fibroid treatment: a cost-effectiveness analysis.

Authors:  Chung Y Kong; Lesley Meng; Zehra B Omer; J Shannon Swan; Serene Srouji; G Scott Gazelle; Fiona M Fennessy
Journal:  AJR Am J Roentgenol       Date:  2014-08       Impact factor: 3.959

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.